Andreas Rink

Dr. Andreas Rink

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2024 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
HLHelmut Lieder
Helmut Lieder
UPUmut Paket
Umut Paket
ASAndreas Skyschally
Andreas Skyschally
ARAndreas Rink
Andreas Rink
TBTheodor Baars
Theodor Baars
GHGerd Heusch
Gerd Heusch
Background and Aims: The spleen serves as an important relay organ that releases cardioprotective factor(s) upon vagal activation during remote ischaemic conditioning (RIC) in rats and pigs. The translation of these findings to humans was attempted. Methods: Remote ischaemic conditioning or electrical auricular tragus stimulation (ATS) were performed in 10 healthy young volunteers, 10 volunteers with splenectomy, and 20 matched controls. Venous blood samples were taken before and after RIC/ATS or placebo, and a plasma dialysate was infused into isolated perfused rat hearts subjected to global ischaemia/reperfusion. Results: Neither left nor right RIC or ATS altered heart rate and heart rate variability in the study cohorts. With the plasma dialysate prepared before RIC or ATS, respectively, infarct size (% ventricular mass) in the recipient rat heart was 36 ± 6% (left RIC), 34 ± 3% (right RIC) or 31 ± 5% (left ATS), 35 ± 5% (right ATS), and decreased with the plasma dialysate from healthy volunteers after RIC or ATS to 20 ± 4% (left RIC), 23 ± 6% (right RIC) or to 19 ± 4% (left ATS), 26 ± 9% (right ATS); infarct size was still reduced with plasma dialysate 4 days after ATS and 9 days after RIC. In a subgroup of six healthy volunteers, such infarct size reduction was abrogated by intravenous atropine. Infarct size reduction by RIC or ATS was also abrogated in 10 volunteers with splenectomy, but not in their 20 matched controls. Conclusions: In humans, vagal innervation and the spleen as a relay organ are decisive for the cardioprotective signal transduction of RIC and ATS.

8 February 2023 in coloproctology
Verified
Journal Article
Closed access
PDF file
ARAndreas Rink
Andreas Rink

16 March 2021 in International Journal of Colorectal Disease
Verified
Journal Article
Open access
PDF file
ARAndreas Rink
Andreas Rink
VGVitaly Golubev
Vitaly Golubev
BVBoris Vestweber
Boris Vestweber
CPClaudia Paul
Claudia Paul
HLHauke Lang
Hauke Lang
KVKarl-Heinz Vestweber
Karl-Heinz Vestweber
Purpose: Single-incision laparoscopic surgery (SILS) has been introduced as a less invasive alternative to multi-port laparoscopic surgery (MLS). MLS is widely accepted for the treatment of colorectal cancer, but there remains minimal evidence for the use of SILS. Thus, we compared both short- and long-term outcomes of SILS and open surgery (OS) in matched cohorts of colorectal cancer patients. Methods: Some 910 patients had colorectal resections for cancer between 2006 and 2013, and 134 of them were operated on using SILS. Eighty of these SILS patients were compared to a cohort of patients who had open surgery that were matching in tumour stage and location, type of resection, sex, age and ASA Score. Disease-free survival at 5 years (5y-DFS) was the primary endpoint; morbidity and hospitalization were secondary parameters. The role of surgical training in SILS was also investigated. Results: Clavien Dindo ≥ IIIb complications occurred in 13.8% in both groups. 5y-DSF were 82% after SILS and 70% after OS (p = 0.11). Local recurrence after rectal cancer tended to be lower after SILS (0/43 (SILS) vs. 4/35 (OS), p = 0.117). Length of stay was significantly shorter after SILS (10 vs. 14 days, p = 0.0004). The rate of operations performed by surgical residents was equivalent in both groups (44/80 (SILS) vs. 46/80 (OS), p = 0.75). Conclusion: The data demonstrates that SILS results in similar long-term oncological outcomes when compared to open surgery as well as morbidity rates. The hospital stay in the SILS group was shorter. SILS can also be incorporated in surgical training programmes.

30 October 2025 in Colorectal Disease
Verified
Journal Article
Open access
PVPaul F. Vollebregt
Paul F. Vollebregt
CBCoen I. M. Baeten
Coen I. M. Baeten
ADAsbjørn M. Drewes
Asbjørn M. Drewes
FMFranco Marinello
Franco Marinello
JMJacopo Martelluci
Jacopo Martelluci
TGThe ADVISABLE Working Group
The ADVISABLE Working Group
Aim: The aims of the study were to: (1) update a systematic review on the efficacy of transanal irrigation (TAI) in patients with chronic constipation (CC) and/or faecal incontinence (FI); (2) provide guidance on the position of TAI in the treatment pathway of CC and FI; and (3) discuss knowledge gaps and areas of future research. Method: A collaborative of 11 experts (gastroenterologists, colorectal surgeons, and clinical scientists) from eight European countries was established. The expert group was divided into three main groups, with each group leading a specific section (systematic review, treatment pathway, and knowledge gaps). A previously published systematic review on TAI was updated by conducting an additional search on 12 April 2025. Studies on TAI in specific subgroups (neurogenic bowel dysfunction, low anterior resection syndrome) were excluded. Results: Sixteen studies involving 1567 (range 16–507) patients were included. Only one underpowered randomised trial was performed, which demonstrated that high‐volume TAI may be more effective than low‐volume TAI in patients with CC. Most other studies (observational) showed improvement in symptoms and/or quality of life to some extent, with a large variation in outcomes used. Treatment discontinuation was reported in 3–57% of patients. The position of TAI in the treatment pathway of CC and FI was proposed, and 13 knowledge gaps were provided. Conclusion: TAI may be an effective treatment in patients with CC and/or FI. There is a need for randomised controlled trials to study its efficacy and current knowledge gaps.

30 May 2025 in Colorectal Disease
Verified
Journal Article
Open access
PMPhil Meister
Phil Meister
SVSamira Vestweber
Samira Vestweber
JNJan Neuhaus
Jan Neuhaus
MRMarc A. Reschke
Marc A. Reschke
UNUlf Neumann
Ulf Neumann
ARAndreas Rink
Andreas Rink
Aim: The incidence of colorectal carcinoma (CRC) in transplant (TX) recipients is higher than in the general population. Registry data indicate inferior oncological outcomes for this population. While the general surgical risk is increased in TX recipients, the risk associated with elective CRC surgery in this population is not well investigated.Methods: TX recipients, who underwent elective surgical treatment for CRC at our specialized centre from 2008 to 2024 were included in this case–control study. The controls were randomly selected from our CRC database and matched according to tumour location and Charlson Comorbidity Index. Outcomes assessed included intensive care unit stay, in‐hospital mortality, length of hospital stay and major morbidity (defined as Clavien–Dindo Grade ≥3).Results: The study included 24 TX recipients. Ten patients had had either liver or kidney TX, three patients had undergone lung TX and one patient heart TX. The mean time interval between transplantation surgery and CRC was 8.82 years. Morbidity was significantly higher in the TX group (54.2% vs. 8.3%, P = 0.001; OR 13.0, 95% CI 2.5–68,1, P = 0.002) and length of hospital stay was significantly longer (25 vs. 9 days, P = 0.001; OR 9.09, 95% CI 1.4–16.7, P = 0.022) for TX patients. No significant differences in mortality and intensive care unit stay were observed.Conclusions: The risk of surgery for CRC in TX patients is significantly increased. Treatment decisions should involve TX experts to develop a tailored and considered treatment plan.

26 November 2025 in coloproctology
Verified
Journal Article
Open access
PDF file
ARAndreas Rink
Andreas Rink
AFAlois Fürst
Alois Fürst
FAFelix Aigner
Felix Aigner